RecruitingNCT07516886
Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Studying Autoimmune polyendocrinopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lithuanian University of Health Sciences
- Principal Investigator
- Daimantas Milonas, MD, PhD, ProfessorLietuvos sveikatos mokslų universitetas
- Intervention
- Radical Prostatectomy(procedure)
- Enrollment
- 500 target
- Eligibility
- 18 years · MALE
- Timeline
- 2024 – 2039
Study locations (1)
- Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology, Kaunas, Kauno, Lithuania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07516886 on ClinicalTrials.govOther trials for Autoimmune polyendocrinopathy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07202598Randomized Stepped Wedge Study of Emapalumab in APECED EnteritisNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGPHASE2NCT05398809Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT05578105Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in TaiwanNational Taiwan University Hospital